Have you ever been puzzled by a critically ill patient in the ICU reporting vivid visual hallucinations, seemingly detached from other typical delirium symptoms or psychosis? Identifying the underlying cause of these perceptions is crucial, especially when the patient’s condition is already compromised. This article serves as a comprehensive guide to understanding visual hallucinations within the context of critical care medicine, offering a framework for differential diagnosis, workup strategies, and treatment approaches.
Decoding Visual Hallucinations: A Diagnostic Challenge
Visual hallucinations, defined as perceiving objects or events through sight without external stimuli, present a significant diagnostic challenge in critical care. While often associated with psychiatric conditions, they are far from exclusive to them, frequently emerging as symptoms of underlying medical and neurological illnesses, particularly in the vulnerable critical care population. In the intensive care unit (ICU) setting, where patients are already battling severe illness, pinpointing the etiology of visual hallucinations is paramount for effective management and improved patient outcomes. Misattributing these symptoms solely to a psychiatric disorder can delay crucial interventions for the actual underlying medical cause.
Visual hallucinations are sensory misperceptions that can stem from a diverse range of factors. This discussion will delve into the potential mechanisms behind visual hallucinations, offering a structured differential diagnosis with a specific focus on conditions commonly encountered in medical and surgical critical care. Effective treatment hinges on accurately diagnosing the root cause, making timely recognition and a thorough understanding of the causative mechanisms essential in the critical care environment.
Unraveling the Mechanisms of Visual Hallucinations
Several theories attempt to explain the origins of visual hallucinations, broadly categorized into psychophysiologic (structural brain disturbances), psychobiochemical (neurotransmitter imbalances), and psychodynamic (unconscious emergence) factors, as outlined by Asaad and Shapiro.1 These categories are not mutually exclusive; visual hallucinations can arise from a complex interplay of brain structure, chemistry, past experiences, and psychological undercurrents.
Currently, a singular neural mechanism fails to account for all types of visual hallucinations. However, the recurring patterns observed across various conditions suggest the existence of a common final pathway. Manford and Andermann2 proposed three primary pathophysiological mechanisms to explain complex visual hallucinations, each with implications for visual diagnosis in critical care.
Firstly, cortical irritation, such as seizure activity, can disrupt normal visual processing. Irritation of the primary visual cortex (Brodmann’s area 17) typically leads to simple, elementary visual hallucinations, whereas involvement of the visual association cortices (Brodmann’s areas 18 and 19) often results in more complex visual experiences.3 Electroencephalographic (EEG) studies and direct cortical stimulation experiments support this model.2 In critical care, where seizures can be subtle or non-convulsive, recognizing these visual manifestations is crucial.
Secondly, deafferentation of the visual system, caused by lesions, can trigger cortical release phenomenon, including visual hallucinations.4 This theory posits that normal visual input is regulated by inhibitory processes, which are diminished or removed by deafferentation. Deafferented neurons may then undergo biochemical and molecular changes, increasing their excitability, similar to the hypersensitivity seen in phantom limb syndrome.5 In critical care, this mechanism is relevant in conditions causing sensory deprivation or neurological damage. Prolonged visual deprivation itself can induce visual hallucinations. A study showed that a significant portion of healthy individuals experienced visual hallucinations after just five days of blindfolding, highlighting the impact of reduced sensory input.7 This is particularly relevant in sedated or immobilized ICU patients.
Thirdly, the reticular activating system, critical for maintaining arousal, is implicated in the genesis of visual hallucinations. Brainstem lesions, as seen in peduncular hallucinosis, can lead to visual hallucinations. Furthermore, their increased occurrence in sleep disorders and drowsiness points to the reticular activating system’s role, although the precise mechanism remains unclear. In critical care, altered arousal levels due to sedation, medications, or underlying illness frequently contribute to visual disturbances.
Differential Diagnosis: Conditions Presenting with Visual Hallucinations in Critical Care
Visual hallucinations in critical care can be a symptom of diverse underlying conditions. A systematic differential diagnosis is crucial for accurate visual diagnosis and targeted treatment.
Psychosis (Schizophrenia/Schizoaffective Disorder)
While primarily auditory, hallucinations in psychotic disorders like schizophrenia can also be visual. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), lists hallucinations as a primary diagnostic criterion for these conditions.8 Visual hallucinations in schizophrenia can range from 16% to 72% of patients, with higher prevalence correlating with illness severity.9 These hallucinations often involve vivid scenes with familiar figures, religious imagery, or animals.10 However, in the critical care setting, attributing visual hallucinations solely to a primary psychotic disorder without considering other medical etiologies would be a critical error.
Delirium
Delirium, characterized by acute disturbances in consciousness and attention, is a common syndrome in critical care, triggered by various medical conditions, metabolic imbalances, infections, medications, and intracranial processes. Delirium frequently manifests with psychotic symptoms, including hallucinations and delusions, often mimicking primary psychiatric illness.12,13 Visual hallucinations are the most prevalent type of hallucination in delirium, reported in a significant percentage of patients.14 A strong correlation exists between visual hallucinations and the number of co-existing medical diagnoses in delirious patients.14 In critical care, where patients often have multiple complex medical issues, delirium must be a primary consideration in the differential diagnosis of visual hallucinations.
Alcohol withdrawal delirium (delirium tremens) and stimulant intoxication are frequently accompanied by visual hallucinations, often involving insects crawling sensations, possibly due to concurrent tactile disturbances.15 Insect hallucinations are more commonly associated with stimulant intoxication compared to schizophrenia.16 Hallucinations due to substance-related causes can fluctuate in duration and intensity, contributing to agitation in critically ill patients.
Dementia
Dementia with Lewy bodies (DLB), the second most common dementia type, is characterized by parkinsonism, cognitive fluctuations, and visual hallucinations. Visual hallucinations are present in over 20% of DLB patients.18 These hallucinations are typically complex, involving moving objects or detailed scenarios of people and objects not actually present. Patients may retain insight into the hallucinatory nature of these perceptions. Visual hallucinations serve as a crucial diagnostic clue differentiating DLB from Alzheimer’s disease.19 Lewy bodies in temporal structures like the amygdala and parahippocampus correlate strongly with well-formed visual hallucinations.20 While less commonly the primary diagnosis in the ICU, pre-existing dementia can predispose critically ill patients to delirium and visual hallucinations.
Parkinson’s disease also presents with visual hallucinations in up to half of patients.21 These are similar to DLB hallucinations, ranging from simple figures to complex scenes with moving people, animals, or objects.22 The distinction between DLB and Parkinson’s disease dementia lies primarily in the timing of symptom onset, with motor symptoms preceding cognitive decline in Parkinson’s disease and vice versa in DLB.23
Posterior cortical atrophy, another neurodegenerative syndrome, can also involve visual hallucinations and parkinsonian features. Pathologically similar to Alzheimer’s but localized to occipital and parietal lobes, it can manifest with visual agnosia, apraxia, and Gerstmann syndrome features.24 Neuroimaging reveals atrophy in bilateral occipital, parietal, and posterior temporal lobes.25
Charles Bonnet Syndrome (CBS)
CBS involves visual hallucinations in visually impaired individuals. Any cause of visual impairment, including macular degeneration, glaucoma, cataracts, cerebrovascular disease, and tumors, can be associated with CBS. While considered a non-psychiatric cause, pre-existing cognitive impairment or dementia may increase susceptibility to CBS.26 Patients may hesitate to report CBS hallucinations due to stigma.
CBS hallucinations are typically clear and detailed, often involving people, faces, animals, and objects. A hallmark of CBS is the eventual insight patients develop regarding the hallucinatory nature of these images.26 CBS is thought to be a cortical release phenomenon. Risk factors include bilateral visual impairment, declining vision, cerebral damage, cognitive deficits, social isolation, and sensory deprivation.26 Vision improvement is the primary treatment, and while antipsychotics and SSRIs have been tried, evidence supporting their use is limited.27–29 In critical care, CBS might be overlooked but should be considered in patients with pre-existing visual impairments and new-onset visual hallucinations.
Anton’s Syndrome
Anton’s syndrome is a rare condition where cortically blind patients deny their visual loss, a combination of anosognosia and confabulation.30 It can take time to recognize the blindness, often discovered when the patient bumps into objects while offering illogical explanations for not seeing them.
The mechanism is unclear but likely involves infarction of the primary visual cortex (Brodmann’s area 17) with preserved visual association cortices function. Emotional reactivity changes may contribute to denial.31 Prevalence is unknown, with a study showing only a small percentage of cortically blind patients denying their blindness.32 Memory impairment might play a role, or synesthetic translation of other senses into perceived vision has been suggested.33 Anton’s syndrome, while rare, underscores the importance of objective neurological assessment in patients presenting with visual hallucinations and apparent visual impairment in critical care.
Seizures
Seizure-induced visual hallucinations are often simple, brief, and consistent for each individual, typically described as small, brightly colored spots or shapes that flash.34,35 Hallucination content may be distorted in size or shape,36 moving from the periphery to the center of vision. Unilateral hallucinations suggest contralateral seizure origin. Complex visual hallucinations from seizures likely involve the visual association cortex.2 Occipital seizures frequently involve visual manifestations.35
Postictal headache can make occipital seizures difficult to differentiate from migraines, delaying appropriate treatment. However, occipital seizure symptoms differ significantly from migraine aura in color, shape, size, location, movement, duration, and development.35 While traditionally described as simple, complex formed visual hallucinations can also occur as ictal, peri-ictal, or intra-ictal phenomena,37,[38](#bib38] sometimes as part of a broader ictal psychosis with delusions and paranoia, mimicking primary psychotic disorders, especially with complex partial seizures. This distinction can be a point of contention between neurologists and psychiatrists.39 In critical care, where seizure threshold can be lowered by various factors, recognizing seizure-related visual hallucinations is vital.
Migraines
Migraine-associated visual hallucinations can manifest as classic migraine aura or less common presentations like migraine coma and familial hemiplegic migraine. Migraine prevalence is significant, with a substantial proportion experiencing aura, almost always with visual symptoms.40,41 Classic visual aura begins as a flickering, uncolored, unilateral zigzag line in the central visual field, progressing peripherally, often leaving a scotoma, lasting under 30 minutes (usually <60 minutes). Variations, including colored patterns, occur. Simple visual hallucinations are most common, but complex hallucinations can occur in migraine coma and familial hemiplegic migraine.
fMRI studies suggest migraine aura is caused by cortical spreading depression, involving brief hyperperfusion followed by slow hypoperfusion, likely neuronal dysfunction rather than primary vascular events.41,43 Migraines are a common cause of visual disturbances and must be considered in the differential diagnosis, even in the critical care setting, particularly in patients with a history of migraines.
Peduncular Hallucinosis
Peduncular hallucinosis is characterized by visual hallucinations following midbrain infarction, first described by Lhermitte in 1922. The mechanism is complex and lesion location varies, often involving the reticular formation or its targets, though cerebral peduncles can be affected.2,[44](#bib44] Hallucinations are thought to be a release phenomenon, often vivid and colorful, with people, animals, and patterns.44 They typically start within days of the insult, resolving within weeks but can persist for years, lasting minutes to hours, often occurring in the evening. Patients develop insight and may find them interesting or amusing.2 In critical care, peduncular hallucinosis is a rarer consideration but should be considered in patients with brainstem infarcts presenting with visual hallucinations.
Sleep Disturbances
Hypnagogic hallucinations occur at sleep onset, while hypnopompic hallucinations occur upon awakening. They are often visual, bizarre, and dreamlike, but with some preserved consciousness.45 Prevalence of hypnagogic hallucinations is significant, and hypnopompic hallucinations are also relatively common.46 Insomnia, excessive daytime sleepiness, and mental disorders increase the likelihood of these hallucinations. They are frequently associated with narcolepsy and are part of its diagnostic criteria, although reported by only a minority of narcoleptics.47 In critical care, sleep disruption is rampant, and hypnagogic/hypnopompic hallucinations may occur but are less likely to be the primary diagnostic concern compared to delirium or other medical causes.
Drug Effects
Many drugs are labeled hallucinogens, altering perceptions,48 though true hallucinations are perceptions without stimuli. Hallucinogenic drugs (mescaline, psilocybin, LSD) are serotonin 5-HT2A receptor agonists, not always causing true hallucinations unless in high doses. Effects are influenced by user mood and context. Other drugs considered hallucinogenic include PCP, ecstasy, atropine, and dopamine agonists. In critical care, medication side effects and drug interactions are crucial considerations. Many medications, including sedatives, analgesics, and anticholinergics, can induce visual hallucinations, particularly in vulnerable patients. A thorough medication review is essential in the visual diagnosis process.
Tumors
Tumors along or compressing the optic pathway can cause visual hallucinations. Temporal lobe tumors can cause complex visual hallucinations, sometimes involving vivid scenes of people performing mundane tasks, often related to tumor-induced seizure activity.49 Occipital tumors are less frequently associated with visual hallucinations, which are typically simpler, unformed spots or lights, resembling occipital seizure hallucinations, suggesting complex formed hallucinations are less likely from occipital tumors.50 Brain tumors, though less common, should be considered in the differential diagnosis, especially with persistent or progressive visual hallucinations, warranting neuroimaging in the diagnostic workup.
Inborn Errors of Metabolism
Certain rare inborn errors of metabolism can cause visual hallucinations. While uncommon, they are important to consider as early diagnosis and treatment can prevent serious neurological damage.51 Specific inborn errors associated with visual hallucinations include homocysteine remethylation defects, urea cycle defects, GM2 gangliosidosis, Niemann-Pick disease type C, and α-mannosidosis. In critical care, considering these is less common in adult-onset hallucinations but may be relevant in younger patients or those with unexplained neurological symptoms.
Creutzfeldt-Jakob Disease (CJD)
CJD is a fatal neurodegenerative prion disease.52 Early symptoms include fatigue, anxiety, and personality changes, progressing to dementia, ataxia, and myoclonus. Visual hallucinations can occur, especially in the Heidenhain variant, with visual effects ranging from color changes and field defects to cortical blindness, metamorphopsia, micropsia, and frank visual hallucinations.53 EEG in Heidenhain variant CJD shows characteristic periodic non-generalizing complexes over the occipital region.54 CJD, though rare, is a critical diagnosis to consider, particularly in rapidly progressive neurological decline with visual symptoms in critical care.
Determining the Etiology of Visual Hallucinations: A Diagnostic Algorithm in Critical Care
Given the extensive differential diagnosis, accurate etiology determination is crucial for effective treatment. A thorough history and clinical examination remain paramount in the workup of visual hallucinations, especially in critical care where patient communication may be limited. Associated symptoms and hallucination characteristics are key diagnostic clues (Table 1). Eliciting signs or symptoms of psychosis, inattention, parkinsonism, visual impairment, or headache narrows the diagnostic possibilities and guides further investigations.
EEG is a highly informative diagnostic tool, capable of detecting seizure activity, delirium (theta-delta slowing), delirium tremens (rapid beta activity), and CJD (occipital periodic non-generalizing complexes).54,55 In critical care, continuous EEG monitoring may be necessary to capture subtle seizure activity or monitor for delirium severity.
Brain MRI can reveal tumors or infarcts responsible for Anton’s syndrome or peduncular hallucinosis and may show the “pulvinar sign” associated with CJD. Neuroimaging is essential in critical care to rule out structural brain lesions.
Treatment Strategies for Visual Hallucinations in Critical Care
Effective treatment of visual hallucinations (Table 2) is contingent on accurate diagnosis of the underlying cause. Diagnostic precision is critical, as treatments beneficial for one etiology may worsen another. For instance, benzodiazepines are the treatment of choice for delirium tremens but can exacerbate delirium from other causes. In critical care, where polypharmacy is common and drug interactions are a concern, targeted treatment is even more crucial.
Neuroleptic medications (dopamine antagonists) are the primary treatment for visual hallucinations due to primary psychotic illness and are also beneficial for delirium, where hallucinations are thought to be related to endogenous dopamine release. Intravenous haloperidol has the strongest evidence for safety and efficacy in delirium.55 However, in critical care, the use of neuroleptics must be carefully considered, especially in elderly or medically unstable patients, due to potential side effects.
Most neuroleptics can worsen parkinsonian symptoms in DLB or Parkinson’s disease dementia due to their dopamine-blocking activity. Quetiapine and clozapine, with lower dopamine receptor affinity, are preferred in these cases.55 Cholinesterase inhibitors may offer some benefit in posterior cortical atrophy, similar to Alzheimer’s dementia.
Focal causes require focal treatments. Anticonvulsants treat seizures, surgery and radiation address tumors, and triptans or β-blockers manage migraines. Unfortunately, some causes, like CJD, have no definitive treatment. In these cases, neuroleptics may alleviate visual hallucinations and associated distress. Regardless of the cause, reassurance from caregivers is beneficial for most patients with visual hallucinations. Psychotherapeutic interventions, such as cognitive behavioral therapy, can improve insight and coping strategies, particularly in chronic conditions. In critical care, addressing the patient’s anxiety and distress related to visual hallucinations is an important aspect of supportive care.
Conclusion: Enhancing Visual Diagnosis in Critical Care
Visual hallucinations in critical care present a complex diagnostic challenge, demanding a systematic and comprehensive approach. By understanding the diverse etiologies, mechanisms, and diagnostic tools available, clinicians can improve their visual diagnosis accuracy and provide targeted, effective treatment. A thorough clinical evaluation, coupled with appropriate investigations like EEG and neuroimaging, is essential to differentiate between various medical, neurological, and psychiatric causes. In the critical care setting, where timely and accurate diagnosis is paramount, a heightened awareness of visual hallucinations and their differential diagnosis is crucial for optimizing patient care and outcomes.
REFERENCES
[1] Asaad G, Shapiro B. Hallucinations: theoretical and clinical overview. Am J Psychiatry. 1986 Nov;143(9):1088-97. PubMed
[2] Manford M, Andermann F. Complex visual hallucinations. Clinical and neurophysiological correlates. Brain. 1998 Dec;121 ( Pt 10):1819-40. PubMed
[3] Geschwind N. Localization of higher functions: cerebral dominance and handedness. In: Williams D, ed. Neurological disorders, Part 1. New York: Hafner; 1970:177–94
[4] Siegel RK. Visual hallucinations. In: Siegel RK, West LJ, eds. Hallucinations: behavior, experience, and theory. New York: John Wiley & Sons; 1975:105–32
[5] Melzack R. Phantom limbs. Sci Am. 1992 Apr;266(4):120-6. PubMed
[6] Damasio AR. The neural basis of memory, language, and behavior. In: Kandel ER, Schwartz JH, Jessell TM, eds. Principles of neural science. 3rd ed. New York: Elsevier; 1991:853–73
[7] Zubek JP, Shephard JM, Milstein SL. Visual sensory deprivation: prolonged perceptual and cognitive effects. Science. 1970 Jan 23;167(3917):401-2. PubMed
[8] American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994
[9] Mueser KT, Cohen NL, Hall JA. Visual hallucinations in schizophrenia: phenomenology and etiological hypotheses. Schizophr Bull. 1990;16(1):69-84. PubMed
[10] Cummings JL. Organic psychosis. Delirium, dementia, and drug abuse. Psychiatr Clin North Am. 1986 Mar;9(1):31-47. PubMed
[11] Goodwin FK, Jamison KR. Manic-depressive illness. New York: Oxford University Press; 1990
[12] Breitbart W, Marotta R, Platt MM, et al. A comparative trial of haloperidol, chlorpromazine, and lorazepam for the treatment of delirium in hospitalized AIDS patients. AIDS. 1996 Jan;10(1):9-14. PubMed
[13] Fernandez F, Holmes VF, Adams F, Kavanaugh J. Consultation-liaison psychiatry and human immunodeficiency virus infection. Psychosomatics. 1988 Winter;29(1):33-44. PubMed
[14] Webster JS, Holroyd S. Prevalence of psychotic symptoms in delirium. Psychosomatics. 1989 Fall;30(4):407-10. PubMed
[15] Stern TA, Gorbach F, Hall JE, Seager JM, Mines MF, Stern TW. Delirium and withdrawal syndromes. In: Stern TA, Herman JB, Slavin PL, eds. Massachusetts General Hospital comprehensive clinical psychiatry. Philadelphia: Mosby; 2008:349–64
[16] Siegel RK. Cocaine hallucinations. Am J Psychiatry. 1978 Mar;135(3):309-14. PubMed
[17] McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996 Dec;47(5):1113-24. PubMed
[18] Ballard C, Holmes C, McKeith I, et al. 10-year follow-up study of dementia with Lewy bodies: survival and conversion to dementia with Alzheimer neuropathology. Arch Neurol. 2002 Dec;59(12):1916-22. PubMed
[19] Tiraboschi P, Hansen LA, Alford M, et al. Visual hallucinations in pathologically confirmed dementia with Lewy bodies and Alzheimer disease. Neurology. 2006 Apr 25;66(8):1101-3. PubMed
[20] Harding AJ, Halliday GM, Caine D, Kril JJ. Degeneration of subcortical nuclei differentiates dementia with Lewy bodies from Alzheimer’s disease. Brain. 2002 Jan;125(Pt 2):280-95. PubMed
[21] Goetz CG, Stebbins GT. Mortality and dementia in Parkinson’s disease. Mov Disord. 1995 Sep;10(5):541-4. PubMed
[22] Fénelon G, Mahieux F, Huon R, Ziégler M. Hallucinations in Parkinson’s disease: prevalence, phenomenology and risk factors. Brain. 2000 Apr;123 ( Pt 4):733-45. PubMed
[23] Lippa CF, Duda JE, Grossman M, et al. DLB and PDD boundary issues: suggested criteria for separation. Neurology. 1998 Mar;50(3):636-41. PubMed
[24] Benson DF, Davis RJ, Snyder BD. Posterior cortical atrophy. Arch Neurol. 1988 Jul;45(7):789-94. PubMed
[25] Hof PR, Vogt BA, Pierot L, Bouras C. Visual agnosia in posterior cortical atrophy: clinicopathologic correlations. Acta Neuropathol. 1993;86(3):252-9. PubMed
[26] Schultz G, Melzack R. The Charles Bonnet syndrome. Pain. 1991 Oct;47(2):159-63. PubMed
[27] Gold K, Rabins PV. Isolated visual hallucinations and Charles Bonnet syndrome: review of the literature and presentation of six cases. J Nerv Ment Dis. 1989 Feb;177(2):91-4. PubMed
[28] Teunisse RJ, Cruysberg JR, Hoefnagels WH, Verbeek AL, Zitman FG. Charles Bonnet syndrome: a systematic review of the literature. J Psychosom Res. 1995 Nov;39(8):1041-50. PubMed
[29] Cox TM, ffytche DH. The Charles Bonnet syndrome: a review. J Neurol Neurosurg Psychiatry. 2000 Sep;69(3):306-15. PMC free article. PubMed
[30] Anton G. Ueber den Selbstmord mit Berücksichtigung der Gehirnverletzungen. Wien Med Wochenschr. 1899;49:2377–84
[31] Critchley M. Anton’s syndrome. Arch Neurol Psychiatry. 1966;16:52–7
[32] Weinstein EA, Cole M. Denial of illness. Symbolic and physiological considerations. Arch Gen Psychiatry. 1965 Jan;12:279-86. PubMed
[33] Nielsen H. Visual agnosia, mind and memory. An historical and clinical study. I. Visual agnosia and aphasia. Brain. 1958 Sep;81(3):430-61. PubMed
[34] Williamson PD, Spencer DD, Spencer SS, Novelly RA, Mattson RH. Complex partial seizures of frontal lobe origin. Ann Neurol. 1985 Feb;18(4):497-504
[35] Panayiotopoulos CP. Elementary visual hallucinations in occipital lobe seizures. J Neurol Neurosurg Psychiatry. 1994 Dec;57(11):1371-5. PMC free article. PubMed
[36] Russell WR, Whitty CW. Studies in traumatic epilepsy. 3. Visual fits. J Neurol Neurosurg Psychiatry. 1955 Aug;18(3):183-96. PMC free article. PubMed
[37] Devinsky O, Kelley K, Porter RJ. Clinical elements of ictal psychosis: a critical review of terminologies and concepts. J Epilepsy. 1988;1(4):279-87. PubMed
[38] Logsdail SJ, Toone BK. Post-ictal psychoses. A clinical and phenomenological study. Br J Psychiatry. 1988 Apr;152:246-52. PubMed
[39] Perez MM, Trimble MR. Epileptic psychosis—diagnostic criteria. J Neurol Neurosurg Psychiatry. 1996 Sep;61(2):105-11. PMC free article. PubMed
[40] Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992 Jan 15;267(1):64-9. PubMed
[41] Goadsby PJ. Migraine aura. Ann Neurol. 2007 Feb;61(2):97-108. PubMed
[42] Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia. 1992 Dec;12(4):221-8. PubMed
[43] Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A. 2001 Jan 16;98(8):4683-8. PMC free article. PubMed
[44] Cascino GD, Biller J. Peduncular hallucinosis. Report of a case, review of the literature, and speculation on the anatomical substrates. J Neuropsychiatry Clin Neurosci. 1991 Fall;3(4):437-42. PubMed
[45] Hong M, Gillin JC, Dow BM, Wu J, Buchsbaum M. Localized and lateralized cerebral metabolism associated with eye movements during REM sleep and wakefulness: PET studies. Sleep. 1995 Apr;18(3):213-20. PubMed
[46] Ohayon MM, Priest RG, Zulley J, Smirne S, Paiva T. Hypnagogic and hypnopompic hallucinations: pathological or normal phenomena? Sleep Med Rev. 1996 Dec;1(3):179-200. PubMed
[47] American Sleep Disorders Association. International classification of sleep disorders, revised: diagnostic and coding manual. Rochester, MN: American Sleep Disorders Association; 1997
[48] Sadock BJ, Sadock VA. Kaplan & Sadock’s comprehensive textbook of psychiatry. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2000
[49] Halgren E, Walter RD, Cherlow DG, Crandall PH. Mental phenomena evoked by electrical stimulation of the human hippocampal formation and amygdala. Brain. 1978 Jun;101(1):83-117. PubMed
[50] Lepore FE. спостереження зорових галюцинацій при пухлинах потиличної частки (Visual hallucinations in tumors of the occipital lobe). Arch Neurol. 1990 Nov;47(11):1174-80. PubMed
[51] Schiffmann R, FitzPatrick D, Mason RW, et al. Clinical characteristics of late-onset Tay-Sachs disease. Medicine (Baltimore). 1999 May;78(3):207-16. PubMed
[52] Prusiner SB. Prions. Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13363-83. PMC free article. PubMed
[53] Geschwind MD, Shu H, Haman A, Devereux G, Raudabaugh BJ, Johnson DY, Miller BL, DeArmond SJ, Prusiner SB. Rapidly progressive dementia in Creutzfeldt-Jakob disease. Ann Neurol. 2008 Feb;63(3):315-24. PMC free article. PubMed
[54] Furlan AJ, Cavalheiro JA, Gomez F, et al. Creutzfeldt-Jakob disease and visual disturbances. Arch Neurol. 1981 Feb;38(2):117-8. PubMed
[55] Stern TA, Rosenbaum JF, Fava M, Biederman J, Rauch SL. Massachusetts General Hospital clinical psychiatry. Philadelphia: Lippincott Williams & Wilkins; 2004
